PTU-induced hypothyroidism modulates antioxidant defence status in the developing cerebellum.
The objective of the present study was to evaluate the effect of 6-n-propylthiouracil (PTU)-induced hypothyroidism on oxidative stress parameters, expression of antioxidant defence enzymes, cell proliferation and apoptosis in the developing cerebellum. PTU challenged neonates showed significant decrease in serum T(3) and T(4) levels and marked increase in TSH levels. Significantly elevated levels of cerebellar H(2)O(2) and lipid peroxidation were observed in 7 days old hypothyroid rats, along with increased activities of superoxide dismutase and glutathione peroxidase and decline in catalase activity. In 30 days old hypothyroid rats, a significant decline in cerebellar lipid peroxidation, superoxide dismutase and glutathione peroxidase activity and expression was observed along with an up-regulation in catalase activity and expression. Expression of antioxidant enzymes was studied by Western blot and semi-quantitative rt-PCR. A distinct increase in cell proliferation as indicated by proliferating cell nuclear antigen (PCNA) immunoreactivity was observed in the internal granular layer of cerebellum of 7 days old hypothyroid rats and significant drop in PCNA positive cells in the cerebellar molecular layer and internal granular layer of 30 days old PTU treated rats as compared to controls. In situ end labeling by TUNEL assay showed increased apoptosis in cerebellum of hypothyroid rats in comparison to controls. These results suggest that the antioxidant defence system of the developing cerebellum is sensitive to thyroid hormone deficiency and consequent alterations in oxidative stress status may play a role in regulation of cell proliferation of the cerebellum during neonatal brain development.
Bhanja
S
S
Department of Biotechnology, Utkal University, Vani Vihar, Bhubaneswar 751004, India. shravanibhanja@rediffmail.com <shravanibhanja@rediffmail.com>
Chainy
G B N
GB
D000818:Animals; D000975:Antioxidants / Q000378:metabolism*; D013956:Antithyroid Agents / Q000494:pharmacology*; D002374:Catalase / Q000378:metabolism; D002531:Cerebellum / Q000187:drug effects / Q000254:growth & development / Q000378:metabolism; D005260:Female; D006801:Humans; D006861:Hydrogen Peroxide / Q000494:pharmacology; D007037:Hypothyroidism / Q000139:chemically induced*; D015227:Lipid Peroxidation; D016877:Oxidants / Q000494:pharmacology; D018384:Oxidative Stress; D011247:Pregnancy; D018809:Proliferating Cell Nuclear Antigen / Q000378:metabolism; D011441:Propylthiouracil / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D013482:Superoxide Dismutase / Q000378:metabolism; D017392:Thiobarbituric Acid Reactive Substances / Q000378:metabolism; D013963:Thyroid Hormones / Q000378:metabolism
D000975:Antioxidants; D013956:Antithyroid Agents; D016877:Oxidants; D018809:Proliferating Cell Nuclear Antigen; D017392:Thiobarbituric Acid Reactive Substances; D013963:Thyroid Hormones; D011441:Propylthiouracil; D006861:Hydrogen Peroxide; D002374:Catalase; D013482:Superoxide Dismutase